(Q43834028)

27 November 2017

Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide (English)

1 reference

27 November 2017

1 reference

1 reference

Holstein A

1

1 reference

27 November 2017

Plaschke A

series ordinal

2

1 reference

27 November 2017

Egberts EH

series ordinal

3

1 reference

27 November 2017

language of work or name

1 reference

1 November 2001

1 reference

Diabetes - Metabolism: Research and Reviews

27 November 2017

1 reference

27 November 2017

17

1 reference

27 November 2017

6

1 reference

27 November 2017

467-473

1 reference

Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells

27 November 2017

1 reference

Clinical profile of the novel sulphonylurea glimepiride

21 January 2018

1 reference

Rates of hypoglycemia in users of sulfonylureas.

21 January 2018

1 reference

Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long-acting versus short-acting sulphonylureas

21 January 2018

1 reference

Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): a double-blind comparison with glibenclamide

21 January 2018

1 reference

Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Glimepiride/Glyburide Research Group.

21 January 2018

1 reference

Estimation of the incidence of diabetes in the Federal Republic of Germany based on insurance data. A secondary data analysis of a representative random sample of locally insured persons in the city of Dortmund

21 January 2018

1 reference

Practicality and accuracy of prehospital rapid venous blood glucose determination

21 January 2018

1 reference

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. I. Binding characteristics

21 January 2018

1 reference

Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations in the fasting and postprandial state in normal man.

21 January 2018

1 reference

Extrapancreatic effects of sulfonylureas--a comparison between glimepiride and conventional sulfonylureas.

21 January 2018

1 reference

The effects of acute exercise on metabolic control in type II diabetic patients treated with glimepiride or glibenclamide

21 January 2018

1 reference

Pharmacokinetics and safety of glimepiride at clinically effective doses in diabetic patients with renal impairment

21 January 2018

1 reference

The use of sulphonylureas in the elderly

21 January 2018

1 reference

Causes, management and morbidity of acute hypoglycaemia in adults requiring hospital admission

21 January 2018

1 reference

Hypoglycemia associated hospitalizations in a population with a high prevalence of non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

Glibenclamide-associated hypoglycaemia: a report on 57 cases

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/DMRR.235

1 reference

27 November 2017

1 reference